Downloads

Title Source Documents Date

Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

Form 8937

Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018

33276

33534

34372

31159

View Presentation

35162

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Tweets